BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 11, 2026
Home
»
Newsletters
» BioWorld
BioWorld
March 11, 2010
View Archived Issues
Finding 'Medically Actionable Alleles' in Genomic Haystack
Read More
Biotech's Future: BioWorld Gives You 2020 Vision in 2010!
Read More
Other News To Note
Read More
Stock Movers
Read More
Clinic Roundup
Read More
Financings Roundup
Read More
Facet Biotech Wooed by $722M Acquisition Offer from Abbott
Three months after Biogen Idec Inc. failed to acquire Facet Biotech Corp. for $17.50 per share, Abbott is getting the job done with a $27-per-share offer. (BioWorld Today)
Read More
Immunotherapy Still an 'Option,' Transgene-Novartis Deal Proves
Read More
